Shoulder Innovations (NYSE:SI) Major Shareholder Sells $659,803.20 in Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $23.36, for a total value of $659,803.20. Following the completion of the transaction, the insider owned 2,352,237 shares in the company, valued at $54,948,256.32. This represents a 1.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82.

Shoulder Innovations Stock Performance

SI stock opened at $22.56 on Thursday. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The firm has a market cap of $467.89 million and a price-to-earnings ratio of -0.14. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. The firm has a 50-day simple moving average of $19.65 and a two-hundred day simple moving average of $15.98.

Shoulder Innovations (NYSE:SI) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The firm had revenue of $16.71 million for the quarter. On average, equities analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.

Institutional Trading of Shoulder Innovations

Several large investors have recently made changes to their positions in SI. Deerfield Management Company L.P. purchased a new position in shares of Shoulder Innovations during the 3rd quarter valued at about $6,056,000. Alyeska Investment Group L.P. purchased a new stake in shares of Shoulder Innovations in the third quarter worth about $5,667,000. Vanguard Group Inc. acquired a new stake in Shoulder Innovations during the third quarter worth about $1,836,000. Roubaix Capital LLC grew its holdings in Shoulder Innovations by 61.9% during the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the period. Finally, Millennium Management LLC purchased a new position in Shoulder Innovations during the fourth quarter valued at approximately $1,316,000.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. UBS Group started coverage on Shoulder Innovations in a research report on Tuesday, July 28th. They set a “buy” rating and a $27.00 price target on the stock. Piper Sandler restated an “overweight” rating and set a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Finally, Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday. Six research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Shoulder Innovations currently has an average rating of “Moderate Buy” and an average price target of $22.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.